EXPLORING BINDING MODES OF BENZTROPINE-LIKE INHIBITORS OF DOPAMINE TRANSPORTER
探索苯托品类多巴胺转运蛋白抑制剂的结合模式
基本信息
- 批准号:7723399
- 负责人:
- 金额:$ 0.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-01 至 2009-07-31
- 项目状态:已结题
- 来源:
- 关键词:BenchmarkingBenztropineBindingCobaltCocaineComputer Retrieval of Information on Scientific Projects DatabaseDevelopmentDockingExhibitsFundingGoalsGrantInstitutionMembraneProductionProtocols documentationResearchResearch PersonnelResourcesRunningSimulateSourceStagingStructureStructure-Activity RelationshipSystemTestingTherapeutic AgentsTimeUnited States National Institutes of HealthWateranalogbasedesigndopamine transporterinhibitor/antagonistinsightmolecular dynamicsnanosecondsimulation
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
A development grant of 30,000 SU is requested to run molecular dynamics simulation of benztropine (BZT) with the dopamine transporter (DAT) in explicit membrane and water. The long term goal of the project is to derive the binding modes of BZT-like inhibitors, understand their structure-activity relationship (SAR) in the context of the DAT structure and design inhibitors without psycho-stimulating effects. Highly selective and potent BZT-like DAT inhibitors differ from cocaine-like inhibitors that they exhibit less euphoric effects and thus show promises in developing into anti-cocaine therapeutic agents. BZT-like inhibitors have very different SAR than cocaine-like inhibitors. However, it has never been understood the structural basis for their different SAR. We will investigate the binding modes of BZT analogues to gain structural insights into the SAR of BZT which will help us to design inhibitors without euphoric effects. We request computational time on IU e1350 (Big Red), NCSA Altix (Cobalt) or TACC PowerEdge 1955 (Lonestar) to run simulations by using NAMD. The choice of machine is made based on NAMD Benchmarks (http://www.ks.uiuc.edu/Research/namd/performance.html) which shows that these machines run much faster than other machines on a system of 92K atoms with up to 128 processors by using NAMD 2.6. Our system has about 88K atoms. The equilibration (3 nanoseconds) and production (10 nanoseconds) stages will approximately take 2000 and 7000 SU, respectively. We will test the above machines to compare which runs faster for our system. Then promising binding modes of BZT produced by a simulated-annealing docking protocol will be equilibrated and then the most promising binding modes will be studied by the 10ns production run.
这个子项目是众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JUFANG SHAN其他文献
JUFANG SHAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JUFANG SHAN', 18)}}的其他基金
EXPLORING BINDING MODES OF BENZTROPINE-LIKE INHIBITORS OF DOPAMINE TRANSPORTER
探索苯托品类多巴胺转运蛋白抑制剂的结合模式
- 批准号:
7956258 - 财政年份:2009
- 资助金额:
$ 0.05万 - 项目类别:
相似海外基金
EXPLORING BINDING MODES OF BENZTROPINE-LIKE INHIBITORS OF DOPAMINE TRANSPORTER
探索苯托品类多巴胺转运蛋白抑制剂的结合模式
- 批准号:
7956258 - 财政年份:2009
- 资助金额:
$ 0.05万 - 项目类别:
Benztropine Analogs, Cocaine Abuse Pharmacotherapies
苯甲托品类似物、可卡因滥用药物疗法
- 批准号:
7393231 - 财政年份:2004
- 资助金额:
$ 0.05万 - 项目类别:
Benztropine Analogs, Cocaine Abuse Pharmacotherapies
苯甲托品类似物、可卡因滥用药物疗法
- 批准号:
7489661 - 财政年份:2004
- 资助金额:
$ 0.05万 - 项目类别:
Benztropine Analogs, Cocaine Abuse Pharmacotherapies
苯甲托品类似物、可卡因滥用药物疗法
- 批准号:
7680920 - 财政年份:2004
- 资助金额:
$ 0.05万 - 项目类别:
Benztropine Analogs, Cocaine Abuse Pharmacotherapies
苯甲托品类似物、可卡因滥用药物疗法
- 批准号:
6780224 - 财政年份:2004
- 资助金额:
$ 0.05万 - 项目类别:
Benztropine Analogs, Cocaine Abuse Pharmacotherapies
苯甲托品类似物、可卡因滥用药物疗法
- 批准号:
7221969 - 财政年份:2004
- 资助金额:
$ 0.05万 - 项目类别:
CHLORPROMAZINE/BENZTROPINE IN TREATMENT-RESISTANT SCHIZOPHRENIA
氯丙嗪/苯托品治疗难治性精神分裂症
- 批准号:
3945076 - 财政年份:
- 资助金额:
$ 0.05万 - 项目类别:
CHLORPROMAZINE/BENZTROPINE IN TREATMENT-RESISTANT SCHIZOPHRENIA
氯丙嗪/苯托品治疗难治性精神分裂症
- 批准号:
3922311 - 财政年份:
- 资助金额:
$ 0.05万 - 项目类别:
CHLORPROMAZINE/BENZTROPINE IN TREATMENT-RESISTANT SCHIZOPHRENIA
氯丙嗪/苯托品治疗难治性精神分裂症
- 批准号:
3860296 - 财政年份:
- 资助金额:
$ 0.05万 - 项目类别:
CHLORPROMAZINE/BENZTROPINE IN TREATMENT-RESISTANT SCHIZOPHRENIA
氯丙嗪/苯托品治疗难治性精神分裂症
- 批准号:
3881282 - 财政年份:
- 资助金额:
$ 0.05万 - 项目类别: